DE69228945D1 - Pharmazeutische pentapeptid-zusammensetzung und ihre verwendung - Google Patents

Pharmazeutische pentapeptid-zusammensetzung und ihre verwendung

Info

Publication number
DE69228945D1
DE69228945D1 DE69228945T DE69228945T DE69228945D1 DE 69228945 D1 DE69228945 D1 DE 69228945D1 DE 69228945 T DE69228945 T DE 69228945T DE 69228945 T DE69228945 T DE 69228945T DE 69228945 D1 DE69228945 D1 DE 69228945D1
Authority
DE
Germany
Prior art keywords
glx
pharmaceutical
pentapeptide
pharmaceutically acceptable
composition
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
DE69228945T
Other languages
English (en)
Other versions
DE69228945T2 (de
Inventor
Vadim Tikhonovich Ivanov
Inessa Ivanovna Mikhalyova
Boris Victorovich Vaskovsky
Alexander Nickolaev Mikhaltsov
Vladimir Khatskelevi Khavinson
Vyacheslav Grigorievic Morozov
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
CYTRAN Ltd
Original Assignee
CYTRAN Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by CYTRAN Ltd filed Critical CYTRAN Ltd
Application granted granted Critical
Publication of DE69228945D1 publication Critical patent/DE69228945D1/de
Publication of DE69228945T2 publication Critical patent/DE69228945T2/de
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/04—Linear peptides containing only normal peptide links
    • C07K7/06—Linear peptides containing only normal peptide links having 5 to 11 amino acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/06—Antianaemics
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/795—Porphyrin- or corrin-ring-containing peptides
    • C07K14/805—Haemoglobins; Myoglobins
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/06—Dipeptides
    • C07K5/06104—Dipeptides with the first amino acid being acidic
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Immunology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Genetics & Genomics (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Hematology (AREA)
  • Diabetes (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
DE69228945T 1992-01-02 1992-12-31 Pharmazeutische pentapeptid-zusammensetzung und ihre verwendung Expired - Fee Related DE69228945T2 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US81620592A 1992-01-02 1992-01-02
PCT/US1992/011381 WO1993012810A1 (en) 1992-01-02 1992-12-31 Pharmaceutical pentapeptide compositions and methods of use thereof

Publications (2)

Publication Number Publication Date
DE69228945D1 true DE69228945D1 (de) 1999-05-20
DE69228945T2 DE69228945T2 (de) 1999-09-16

Family

ID=25219964

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69228945T Expired - Fee Related DE69228945T2 (de) 1992-01-02 1992-12-31 Pharmazeutische pentapeptid-zusammensetzung und ihre verwendung

Country Status (10)

Country Link
EP (1) EP0621789B1 (de)
JP (1) JP3348851B2 (de)
AT (1) ATE178800T1 (de)
AU (1) AU3429393A (de)
CA (1) CA2127275A1 (de)
DE (1) DE69228945T2 (de)
DK (1) DK0621789T3 (de)
ES (1) ES2131105T3 (de)
GR (1) GR3030600T3 (de)
WO (1) WO1993012810A1 (de)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5589458A (en) * 1992-11-13 1996-12-31 Thomas Jefferson University Compounds that inhibit T cell proliferation and methods for using the same

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4395404A (en) * 1982-05-14 1983-07-26 George Washington University Synthetic thymosin β3 and β4 analogues
US4753927A (en) * 1983-08-12 1988-06-28 Immunetech Pharmaceuticals Method of blocking immune complex binding to immunoglobulin Fc receptors
US5081108A (en) * 1984-08-24 1992-01-14 Imreg, Inc. Method of showing progression of AIDS in an ARC patient by treating with Tyr-Gly compositions
US5100663A (en) * 1984-08-24 1992-03-31 Imreg, Inc. Tyr-Gly compositions useful in increasing immune response
US5093321A (en) * 1984-08-24 1992-03-03 Imreg, Inc. Dialysates for treating aids and arc and for otherwise increasing immune response
DK0613375T3 (da) * 1991-10-28 2004-07-12 Melmotte Inc Farmaceutiske lysinholdige polypeptidpræparater og anvendelse deraf

Also Published As

Publication number Publication date
ES2131105T3 (es) 1999-07-16
EP0621789A4 (en) 1995-09-06
ATE178800T1 (de) 1999-04-15
EP0621789B1 (de) 1999-04-14
DE69228945T2 (de) 1999-09-16
WO1993012810A1 (en) 1993-07-08
JP3348851B2 (ja) 2002-11-20
GR3030600T3 (en) 1999-10-29
CA2127275A1 (en) 1993-07-08
DK0621789T3 (da) 1999-10-25
AU3429393A (en) 1993-07-28
JPH07506564A (ja) 1995-07-20
EP0621789A1 (de) 1994-11-02

Similar Documents

Publication Publication Date Title
DE69230500D1 (de) Pharmazeutische Dipeptid Zusammensetzungen und Verwendungsmethoden.
BG101118A (en) Therapeutical compounds
FI922325A (fi) Oral sammansaettning foer botning av inflammatoriska tarmkanalsjukdomar.
TR199801180T2 (xx) Aneljestik etkiye sahip yeni bile�ikler.
RU94041223A (ru) Средство для лечения мотонейроновых заболеваний
AU618443B2 (en) The use of the active substance azelastine in combatting psoriasis disorders and inflammatory disorders
RU92016463A (ru) Применение производных цистина для изготовления лекарственных препаратов с иммуномоделирующим действием, фармацевтические композиции на их основе
RU94002133A (ru) 6-хлор-5-фтор-3-(2-теноил)-2-оксиндол-1-карбоксамид как аналгезирующее и противовоспалительное средство
TR199801184T2 (xx) Analjezik tesirli yeni bile�ikler.
DK0613375T3 (da) Farmaceutiske lysinholdige polypeptidpræparater og anvendelse deraf
DE10299023I2 (de) Antineoplastisch wirkender und den antineoplastischen effekt verstärkender wirkstoff
NO810480L (no) Anologifremgangsmaate for fremstilling av terapeutisk aktive 1,3,4-oksadiazolylfenol-derivater
DE69228945D1 (de) Pharmazeutische pentapeptid-zusammensetzung und ihre verwendung
DE68905076D1 (de) Pharmazeutische zusammensetzung fuer die behandlung von hautwunden.
RU94032792A (ru) Применение 5нтiа - антагонистов для прекращения использования табака
SE8804640D0 (sv) Medicament comprising cyclolinopeptide a
MX9303074A (es) Uso de la (e)-2-(p-fluorofenetil)-3-fluoroalilamina en el tratamiento de la enfermedad de elzheimer.
CO5031290A1 (es) Formulacion lo
DE69107083T2 (de) Antibiotikum ge1655-komplex und seine faktoren a,b und c.
DE3777411D1 (de) Mittel zur verbesserung der perkutanen verabreichung von arzneimitteln.
IT1243368B (it) Uso del bendazac e dei suoi sali farmaceuticamente accettabili
IT1264428B1 (it) Composizioni farmaceutiche per il trattamento della psoriasi
UA12937A (uk) Засіб для локальhого лікуваhhя гhійhо-запальhих раh та опіків, іhфіковаhих стафілококом
IT1267664B1 (it) Composizione a base di fosfocreatina e suo uso farmaceutico

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8339 Ceased/non-payment of the annual fee